Zoetis (ZTS) reported $2.47 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 0.3%. EPS of $1.87 for the same period compares to $1.76 a year ago.
The reported revenue represents a surprise of -0.95% over the Zacks Consensus Estimate of $2.49 billion. With the consensus EPS estimate being $1.84, the EPS surprise was +1.63%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Zoetis performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Geographic Revenues- U.S.: $1.27 billion versus $1.33 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -6.6% change. Geographic Revenues- International Revenue: $1.17 billion versus $1.14 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +9.6% change. Geographic Revenues- International- Livestock: $509 million versus $491.12 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +11.1% change. Geographic Revenues- U.S.- Livestock: $222 million compared to the $191.1 million average estimate based on three analysts. The reported number represents a change of +23.3% year over year. Geographic Revenues- International- Companion Animal: $664 million versus $651.08 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +8.5% change. Geographic Revenues- U.S.- Companion Animal: $1.04 billion compared to the $1.14 billion average estimate based on three analysts. The reported number represents a change of -11.2% year over year. Revenues- Livestock: $731 million versus $678.9 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +14.6% change. Revenues- Contract Manufacturing & Human Health: $29 million versus the three-analyst average estimate of $35.13 million. The reported number represents a year-over-year change of -14.7%. Revenues- Companion Animal: $1.71 billion versus the three-analyst average estimate of $1.77 billion. The reported number represents a year-over-year change of -4.5%.View all Key Company Metrics for Zoetis here>>>
Shares of Zoetis have returned -1% over the past month versus the Zacks S&P 500 composite's +3.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Zoetis Inc. (ZTS): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).